PPioneerautohub

Low-Dose Aspirin: Side Effects, Contraindications and Who Should Avoid It

Editorial Team · Section: Organ Protection: Medications · Reading time: 7 min
Low-Dose Aspirin: Side Effects, Contraindications and Who Should Avoid It
Photo: Zoshua Colah / Unsplash

For decades, a daily "baby aspirin" was considered a simple way to protect the heart. Large trials published in 2018 changed that view, and US guidance now recommends a far more selective approach. Our editorial team reviews the side effects and contraindications of low-dose aspirin and explains why it is not a harmless habit for active adults.

How Low-Dose Aspirin Works

Aspirin (acetylsalicylic acid) irreversibly blocks the enzyme cyclooxygenase-1 (COX-1) in platelets. Because platelets have no nucleus, they cannot make new enzyme, so the effect lasts for the platelet's lifespan of roughly 7–10 days.

Blocking COX-1 reduces production of thromboxane A2, a substance that makes platelets stick together. The result is a lower tendency to form clots — useful for preventing heart attacks and strokes in some people, but also the root of aspirin's main side effect: bleeding.

In the United States, "low-dose" usually means 81 mg, while many other countries use 75–100 mg tablets. The Antithrombotic Trialists' Collaboration (2009) meta-analysis confirmed clear benefit in people who already had cardiovascular disease, a setting called secondary prevention.

In primary prevention — people without established disease — the absolute benefit is much smaller, and the bleeding risk becomes a decisive factor.

What the 2018 Trials and 2022 Guidance Changed

Three major trials published in 2018 reshaped practice. ASPREE (McNeil et al.) enrolled healthy adults aged 70 and older and found no reduction in cardiovascular events but a significant increase in major bleeding with daily 100 mg aspirin.

ARRIVE (Gaziano et al.) studied people at moderate cardiovascular risk and found no significant benefit. ASCEND (Bowman et al.) in people with diabetes found fewer vascular events, but the benefit was largely offset by more major bleeding.

Age 40–49: benefit Age 40–49: bleeding Age 60–69: benefit Age 60–69: bleeding Age 70+: benefit Age 70+: bleeding Relative magnitude (schematic)
Fig. 1. Schematic illustration of how the bleeding risk of primary-prevention aspirin grows relative to benefit with age (illustrative, not trial data).

In 2022, the US Preventive Services Task Force (USPSTF) recommended against initiating low-dose aspirin for primary prevention in adults aged 60 or older. For adults aged 40–59 with a 10-year cardiovascular risk of 10% or more, it advised an individual decision, noting the net benefit is small.

These recommendations do not apply to people taking aspirin after a heart attack, stroke, stent or bypass surgery. For them, aspirin remains an important therapy that should not be stopped without medical advice.

Low-Dose Aspirin: Side Effects, Contraindications and Who Should Avoid It — illustration
Photo: Brecht Corbeel / Unsplash

Side Effects

Side effectWhat happensWho is at higher risk
Gastrointestinal bleedingUlcers or bleeding in the stomach or intestineAge 60+, prior ulcer, H. pylori, alcohol, other NSAIDs, anticoagulants
Intracranial bleedingRare but serious brain hemorrhageOlder age, uncontrolled hypertension
DyspepsiaHeartburn, nausea, stomach discomfortSensitive stomach, reflux
Easy bruising and nosebleedsMinor bleedingContact sports participants
Aspirin-exacerbated respiratory diseaseAsthma attacks, nasal polypsPeople with asthma and nasal polyps
Allergic reactionsHives, swelling, rarely anaphylaxisKnown NSAID hypersensitivity

Enteric-coated tablets were designed to reduce stomach irritation, but they do not eliminate the risk of bleeding because the effect on platelets and on the stomach's protective prostaglandins is systemic.

Athletes in contact sports or activities with fall risk — cycling, mountain biking, martial arts — should be aware that even minor trauma may cause more bruising or bleeding while on aspirin.

Some people notice ringing in the ears (tinnitus) at high anti-inflammatory doses; this is uncommon at 81 mg.

Contraindications and Drug Interactions

  1. Active peptic ulcer or recent gastrointestinal bleeding.
  2. Bleeding disorders such as hemophilia or severe thrombocytopenia.
  3. Known allergy to aspirin or other NSAIDs, including aspirin-exacerbated respiratory disease.
  4. Children and teenagers with viral illnesses, because of the risk of Reye's syndrome.
  5. Late pregnancy, unless specifically prescribed (for example, for preeclampsia prevention under obstetric care).
  6. Severe kidney or liver disease.

Combining aspirin with anticoagulants (warfarin, apixaban, rivaroxaban), other antiplatelet drugs, SSRIs, corticosteroids or alcohol increases bleeding risk. Such combinations are sometimes medically necessary but require supervision.

We also highlight szteroid rendeles.

Catella-Lawson and colleagues (2001) showed that ibuprofen taken before aspirin can block aspirin's access to the platelet COX-1 enzyme, reducing its antiplatelet effect. This interaction is relevant for people on cardioprotective aspirin who also use ibuprofen for training aches.

Aspirin can also raise methotrexate levels and may interfere with some gout medications. Pharmacists can review all interactions when you fill a prescription.

Practical Points for Active Adults

Aspirin does not improve athletic performance and is not on the World Anti-Doping Agency prohibited list. Some endurance athletes take it on their own, believing it protects against cardiac events during races, but there is no good evidence for this practice in healthy people.

Bleeding risk combined with dehydration, NSAID use and gastrointestinal stress during long events is a poor mix. Gastrointestinal bleeding in endurance athletes has been described even without medications.

Anyone already taking low-dose aspirin before elective surgery, dental procedures or new medications should inform the medical team, which will decide whether to continue or pause it.

Warning signs that require immediate care include black or bloody stools, vomiting blood or coffee-ground material, sudden severe headache, or weakness on one side of the body.

If you have taken aspirin for years for primary prevention, the 2022 guidance is a good reason to review the decision with your physician rather than stopping suddenly.

Important. This article is for informational purposes only and is not medical advice. Do not start or stop daily aspirin on your own — especially if it was prescribed after a heart attack, stroke or stent. Discuss the decision with your physician.

Editorial Team Conclusions

Low-dose aspirin remains an essential medication for many people with established cardiovascular disease. For healthy adults, especially those over 60, the bleeding risks often outweigh the modest benefit.

Gastrointestinal bleeding, interactions with NSAIDs and anticoagulants, and specific contraindications make aspirin a medication that deserves medical oversight rather than self-prescription.

Our editors also suggest reading about NSAID use in endurance athletes, heart screening for masters athletes, and omega-3 fatty acids for cardiovascular health.

References

  1. Antithrombotic Trialists' (ATT) Collaboration; Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849–1860.
  2. McNeil JJ, Wolfe R, Woods RL, et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med. 2018;379(16):1509–1518.
  3. Gaziano JM, Brotons C, Coppolecchia R, et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet. 2018;392(10152):1036–1046.
  4. ASCEND Study Collaborative Group; Bowman L, Mafham M, Wallendszus K, et al. Effects of aspirin for primary prevention in persons with diabetes mellitus. N Engl J Med. 2018;379(16):1529–1539.
  5. US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, et al. Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement. JAMA. 2022;327(16):1577–1584.
  6. Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. 2001;345(25):1809–1817.
© 2026 PioneerautohubPioneerautohub